TMJ Implants, Inc. v. United States Department of Health & Human Services Case Brief
Complete case briefs with LSD+
Every LSD.Law brief pairs a full IRAC analysis with opinion summaries at three levels of depth, written by a team of Harvard Law and MIT graduates - a quick synopsis when you are pressed for time, the complete reasoning when you need to go deep.
Adaptive Case Views
Toggle between Flash, Standard, and Expanded. Get what you need, when you need it.
Exam-Ready IRAC Format
We deliver the precise structure professors look for in exam answers.
Complex Cases, Clarified
We break down dense legal reasoning into something digestible, helping you grasp core concepts.
Case Brief Summary & Legal Analysis
tl;dr: A medical device manufacturer challenged FDA penalties for failing to report adverse events. The court affirmed, deferring to the FDA’s broad interpretation of its reporting regulations and upholding the agency’s enforcement authority against both the company and its president.
Legal Significance: Reinforces broad agency deference in interpreting statutory reporting requirements. Affirms that an agency can pursue enforcement actions, like civil penalties, even while an internal agency appeal is pending, and confirms the personal liability of responsible corporate officers for regulatory violations.
TMJ Implants, Inc. v. United States Department of Health & Human Services Law School Study Guide
Use this case brief structure for your own legal analysis. Focus on the IRAC methodology to excel in law school exams and cold calls.
Case Facts & Court Holding
Key Facts & Case Background
The Food and Drug Administration (FDA) requires medical device manufacturers to submit a Medical Device Report (MDR) for any information that “reasonably suggests” a device “may have caused or contributed to a … serious injury.” TMJ Implants, Inc. (TMJI) and its president, Dr. Christensen, received information regarding seventeen adverse events, including device explants and medical interventions to treat conditions like pain, infection, and swelling. TMJI argued these were not reportable because the events stemmed from the natural progression of the patient’s disease, not a device failure, and that Dr. Christensen, as a qualified expert, had reasonably concluded the device was not a cause. Despite repeated warnings from the FDA explaining its broad interpretation of the reporting standard, TMJI refused to file the MDRs. TMJI requested an internal agency review of the FDA’s decision. Before that review concluded, the FDA initiated a Complaint for Money Penalties (CMP). An Administrative Law Judge (ALJ) and the Departmental Appeals Board (DAB) upheld penalties of $170,000 each against both TMJI and Dr. Christensen personally. TMJI sought judicial review.
Court Holding & Legal Precedent
Issue: Did the agency’s appellate board err in affirming civil penalties based on its broad interpretation of mandatory reporting regulations and its decision to initiate enforcement while an internal appeal was pending?
No. The court affirmed the final agency decision, holding that the FDA’s Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate v
IRAC Legal Analysis
About IRAC analysis
IRAC (Issue, Rule, Analysis, Conclusion) is the structure professors expect in exam answers. Each LSD.Law brief states the issue, the governing rule with citations, the court's application of that rule, and the conclusion - the same reasoning pattern you will use on exams and in practice.
Legal Issue
Did the agency’s appellate board err in affirming civil penalties based on its broad interpretation of mandatory reporting regulations and its decision to initiate enforcement while an internal appeal was pending?
Conclusion
The case serves as a strong precedent for judicial deference to an Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
Legal Rule
Under the Administrative Procedure Act, agency action is upheld unless it is Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cu
Legal Analysis
The court afforded significant deference to the FDA's interpretation of its own Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis n
Flash-to-Full Case Opinions
Flash Summary
- The Tenth Circuit affirmed civil penalties against a device manufacturer and